Login
From:
Parkinson's News Today
(Uncensored)
subscribe
1st patient dosed in Phase 2 trial of Parkinson's therapy VTX3232
https://parkinsonsnewstoday.com/news/1st-patient-dosed-phase-2-trial-parkinsons-therapy-vtx-3232/
links
backlinks
Tagged with:
clinical trial
nlrp3
The first patient has been dosed in a Phase 2a trial of Parkinson's therapy VTX3232, an oral medication designed to reduce inflammation.
Roast topics
Find topics
Roast it!
Roast topics
Find topics
Find it!
Roast topics
Find topics
Find it!
